Promising Startups 2022
2022 VC Survey
DustPhotonics raises $22 million in Series B follow-on
Palo Alto Networks shares plunge following reduced 2024 forecast
“Israel’s tech sector can recover within months”
SolarEdge slump continues after disappointingly low forecast, widening loss
Sam Altman's $7 trillion chip dream: Bold vision or delusional fantasy?
Mor Assia and Shelly Hod Moyal raise $70 million for second iAngels fund
Back to New York: Who’s who at Calcalist’s Mind the Tech 2024 conference
Profits are at record highs, so why are tech companies laying off so many workers?
Down rounds in Israeli tech hit nearly 20% in 2023
17 stories about Moderna
Moderna’s resigning CMO says he achieved what he cared about
Tal Zaks: I never imagined that I’d develop a vaccine for the worst pandemic of our times
Tal Zaks leaving Moderna after six years as Chief Medical Officer
“Through his leadership over the past year in Moderna’s response to the Covid-19 pandemic, Tal has made a contribution that extends beyond Moderna to all of society,” says CEO
Moderna CMO suggests Israel is on its radar for new vaccine production facility
Tal Zaks says the drugmaker has already produced a booster shot to counter the South African variant, says his mom in Israel received the competition’s vaccine
How is technology and data helping Israel become the first country to vanquish Covid-19?
Israel is well on its way to vaccinating its entire adult population and in exchange for delivering millions of vaccine doses, the government has pledged to give drugmaker Pfizer medical data on the millions of vaccine recipients from the health system’s vast databases
These are the key ingredients of Israel's rapid Covid-19 vaccine rollout recipe
Two weeks into its vaccination drive, Israel has reached nearly 15% of the population by paying premium prices, relying on universal healthcare, and minimizing waste
Moderna says the first shipments of its vaccines is set to arrive in Israel this month
The U.S. drugmaker says Israel is the first county outside of North America to authorize the use of its Covid-19 shots
Will the quickly developed vaccines deliver Covid-19 a knockout blow?
An urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge
Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021
New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
Markets may recover from pandemic soon, says CapitalG investor
Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference
What is Moderna’s chief scientist saying and how does coffee make it to your mug?
CTech Daily Roundup: In the absence of acquisitions, IPOs are swooping in to save the tech scene
Moderna’s chief scientist says company initiated vaccine deal with Israel
Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
Moderna joins Pfizer, says its vaccine is 94.5% effective in preventing Covid-19
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute
As the Covid-19 vaccine arms race intensifies, big money is at risk
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
Place your bets: Which company will reach a Covid-19 vaccine first?
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
Which VC raised $250 million and why is an Israeli tracing app raising privacy concerns?
CTech Daily Roundup: Coronavirus-led protectionism poses a challenge to both our economies, says Irish ambassador to Israel
Israel signs deal to acquire Covid-19 vaccine from Moderna
Ynetnews and CTech
Moderna announced it was concluding its phase two testing for the vaccine and plans to begin phase three with 30,000 participants in July. The company claimed it could start production of the vaccine as soon as September of this year
UI & UX by